By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Anchen Pharmaceuticals(USA), Inc. 

9601 Jeronimo

Irvine  California  92618  U.S.A.
Phone: 949-639-8100 Fax: 949-837-6120



Company News
Sucampo Pharmaceuticals, Inc. (SCMP) Files Patent Infringement Lawsuit Against Anchen Pharmaceuticals(USA), Inc. and Par Pharmaceutical Companies, Inc. (PRX) 2/8/2013 7:19:20 AM
Shire plc Settles All Pending Litigation With Anchen Pharmaceuticals(USA), Inc. and TWi Pharmaceuticals, Inc. Concerning INTUNIV® 9/6/2012 11:03:35 AM
Par Pharmaceutical Companies, Inc. (PRX) Completes Acquisition of Anchen Pharmaceuticals(USA), Inc. 11/18/2011 9:46:05 AM
Shire plc Receives INTUNIV(TM) Paragraph IV Notice Letter From Anchen Pharmaceuticals(USA), Inc. 4/27/2010 11:31:27 AM
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Wellbutrin XL(R) Tablets, 300 Mg Under Agreement With Anchen Pharmaceuticals(USA), Inc. And IMPAX Laboratories, Inc. (IPXL) 12/18/2006 11:29:33 AM
GlaxoSmithKline (GSK) And Biovail Corporation (BVF) Down As Copycat Antidepressant Wins Ruling 8/2/2006 10:55:05 AM
Biovail (BVF) Confirms Receipt Of Notification Of ANDA Submission For Wellbutrin XL; BVF Stock Down10/19/2005 5:12:14 PM
Abrika Pharmaceuticals LLP Responds To Biovail Lawsuit10/19/2005 5:09:37 PM